226 related articles for article (PubMed ID: 25902443)
1. Direct Detection of α-Synuclein Dimerization Dynamics: Single-Molecule Fluorescence Analysis.
Lv Z; Krasnoslobodtsev AV; Zhang Y; Ysselstein D; Rochet JC; Blanchard SC; Lyubchenko YL
Biophys J; 2015 Apr; 108(8):2038-47. PubMed ID: 25902443
[TBL] [Abstract][Full Text] [Related]
2. Effect of acidic pH on the stability of α-synuclein dimers.
Lv Z; Krasnoslobodtsev AV; Zhang Y; Ysselstein D; Rochet JC; Blanchard SC; Lyubchenko YL
Biopolymers; 2016 Oct; 105(10):715-24. PubMed ID: 27177831
[TBL] [Abstract][Full Text] [Related]
3. Site-specific fluorescence dynamics of α-synuclein fibrils using time-resolved fluorescence studies: effect of familial Parkinson's disease-associated mutations.
Sahay S; Anoop A; Krishnamoorthy G; Maji SK
Biochemistry; 2014 Feb; 53(5):807-9. PubMed ID: 24450731
[TBL] [Abstract][Full Text] [Related]
4. Wild-Type
Guzzo A; Delarue P; Rojas A; Nicolaï A; Maisuradze GG; Senet P
Front Mol Biosci; 2022; 9():910104. PubMed ID: 35836937
[No Abstract] [Full Text] [Related]
5. α-Synuclein misfolding assessed with single molecule AFM force spectroscopy: effect of pathogenic mutations.
Krasnoslobodtsev AV; Volkov IL; Asiago JM; Hindupur J; Rochet JC; Lyubchenko YL
Biochemistry; 2013 Oct; 52(42):7377-86. PubMed ID: 24066883
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers.
Brucale M; Sandal M; Di Maio S; Rampioni A; Tessari I; Tosatto L; Bisaglia M; Bubacco L; Samorì B
Chembiochem; 2009 Jan; 10(1):176-83. PubMed ID: 19067456
[TBL] [Abstract][Full Text] [Related]
7. Label-free detection of early oligomerization of α-synuclein and its mutants A30P/E46K through solid-state nanopores.
Li X; Tong X; Lu W; Yu D; Diao J; Zhao Q
Nanoscale; 2019 Mar; 11(13):6480-6488. PubMed ID: 30892349
[TBL] [Abstract][Full Text] [Related]
8. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
[TBL] [Abstract][Full Text] [Related]
9. Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.
Marmolino D; Foerch P; Atienzar FA; Staelens L; Michel A; Scheller D
Mol Cell Neurosci; 2016 Mar; 71():92-101. PubMed ID: 26711807
[TBL] [Abstract][Full Text] [Related]
10. Familial Parkinson disease mutations influence α-synuclein assembly.
Ono K; Ikeda T; Takasaki J; Yamada M
Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
[TBL] [Abstract][Full Text] [Related]
11. Single-molecule FRET studies on alpha-synuclein oligomerization of Parkinson's disease genetically related mutants.
Tosatto L; Horrocks MH; Dear AJ; Knowles TP; Dalla Serra M; Cremades N; Dobson CM; Klenerman D
Sci Rep; 2015 Nov; 5():16696. PubMed ID: 26582456
[TBL] [Abstract][Full Text] [Related]
12. High-speed atomic force microscopy reveals structural dynamics of α-synuclein monomers and dimers.
Zhang Y; Hashemi M; Lv Z; Williams B; Popov KI; Dokholyan NV; Lyubchenko YL
J Chem Phys; 2018 Mar; 148(12):123322. PubMed ID: 29604892
[TBL] [Abstract][Full Text] [Related]
13. Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease.
Kumar S; Sarkar A; Sundar D
Biochem Biophys Res Commun; 2009 Sep; 387(2):305-9. PubMed ID: 19580781
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.
Choong CJ; Say YH
Neurotoxicology; 2011 Dec; 32(6):857-63. PubMed ID: 21658409
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein.
Guan Y; Zhao X; Liu F; Yan S; Wang Y; Du C; Cui X; Li R; Zhang CX
Front Cell Neurosci; 2020; 14():159. PubMed ID: 32595456
[TBL] [Abstract][Full Text] [Related]
16. Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein.
Healey MA; Woodside MT; Tuszynski JA
Eur Biophys J; 2016 May; 45(4):355-64. PubMed ID: 26695014
[TBL] [Abstract][Full Text] [Related]
17. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity.
Sanjeev A; Mattaparthi VSK
J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719
[TBL] [Abstract][Full Text] [Related]
18. Structures and free energy landscapes of the wild-type and A30P mutant-type α-synuclein proteins with dynamics.
Wise-Scira O; Aloglu AK; Dunn A; Sakallioglu IT; Coskuner O
ACS Chem Neurosci; 2013 Mar; 4(3):486-97. PubMed ID: 23374072
[TBL] [Abstract][Full Text] [Related]
19. Effect of spermidine on misfolding and interactions of alpha-synuclein.
Krasnoslobodtsev AV; Peng J; Asiago JM; Hindupur J; Rochet JC; Lyubchenko YL
PLoS One; 2012; 7(5):e38099. PubMed ID: 22662273
[TBL] [Abstract][Full Text] [Related]
20. Nanomolar oligomerization and selective co-aggregation of α-synuclein pathogenic mutants revealed by single-molecule fluorescence.
Sierecki E; Giles N; Bowden Q; Polinkovsky ME; Steinbeck J; Arrioti N; Rahman D; Bhumkar A; Nicovich PR; Ross I; Parton RG; Böcking T; Gambin Y
Sci Rep; 2016 Nov; 6():37630. PubMed ID: 27892477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
